448 related articles for article (PubMed ID: 15486359)
1. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
[TBL] [Abstract][Full Text] [Related]
2. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
4. High-sensitivity C-reactive protein predicts adverse cardiovascular events in patients with Takayasu arteritis with coronary artery involvement.
Wang X; Dang A; Lv N; Liu Q; Chen B
Clin Rheumatol; 2016 Mar; 35(3):679-84. PubMed ID: 25665822
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.
Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD
J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive Protein, Lipoprotein(a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease.
Kumakura H; Fujita K; Kanai H; Araki Y; Hojo Y; Kasama S; Iwasaki T; Ichikawa S; Nakashima K; Minami K
J Atheroscler Thromb; 2015; 22(4):344-54. PubMed ID: 25296963
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Ridker PM; Hennekens CH; Buring JE; Rifai N
N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
9. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
Habib SS
J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
[TBL] [Abstract][Full Text] [Related]
10. [High sensitivity C reactive protein and lipid status as a risk factors for coronary disease].
Nurkić J; Nurkić M; Nurkić M
Med Arh; 2007; 61(3):138-41. PubMed ID: 18232274
[TBL] [Abstract][Full Text] [Related]
11. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
13. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
[TBL] [Abstract][Full Text] [Related]
16. Circulating mononuclear superoxide production and inflammatory markers for long-term prognosis in patients with cardiac syndrome X.
Leu HB; Lin CP; Lin WT; Wu TC; Lin SJ; Chen JW
Free Radic Biol Med; 2006 Mar; 40(6):983-91. PubMed ID: 16540394
[TBL] [Abstract][Full Text] [Related]
17. Adhesion molecules and C-reactive protein are associated to adverse events in angina pectoris.
Eschen O; Christensen JH; Johnsen SP; Dethlefsen C; Schmidt EB
Scand Cardiovasc J; 2010 Jun; 44(3):153-60. PubMed ID: 20184510
[TBL] [Abstract][Full Text] [Related]
18. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
20. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
